nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A retrospective cohort study of the efficacy and safety of oral azvudine versus nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 years
|
Yu, Bo |
|
|
15 |
3 |
p. 1333-1343 |
artikel |
2 |
A synthetic peptide, derived from neurotoxin GsMTx4, acts as a non-opioid analgesic to alleviate mechanical and neuropathic pain through the TRPV4 channel
|
Ke, ShaoXi |
|
|
15 |
3 |
p. 1447-1462 |
artikel |
3 |
Author correction to “Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice” [Acta Pharm Sin B 11 (2021) 1200–1212]
|
Zhu, Yuyu |
|
|
15 |
3 |
p. 1719-1720 |
artikel |
4 |
Author correction to “Up-regulation of glyclipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication” [Acta Pharm Sin B 9 (2019) 769–781]
|
Huang, Menghao |
|
|
15 |
3 |
p. 1721 |
artikel |
5 |
Bispecific killer engager for targeted depletion of PD-1 positive lymphocytes: A new avenue for autoimmune disease treatment
|
Naatz, Lauren C. |
|
|
15 |
3 |
p. 1230-1241 |
artikel |
6 |
BRD4 regulates m6A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression
|
Zhang, Haisheng |
|
|
15 |
3 |
p. 1552-1570 |
artikel |
7 |
CDK5-triggered G6PD phosphorylation at threonine 91 facilitating redox homeostasis reveals a vulnerability in breast cancer
|
Bei, Yuncheng |
|
|
15 |
3 |
p. 1608-1625 |
artikel |
8 |
Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer's disease
|
Ashwini, Patil |
|
|
15 |
3 |
p. 1281-1310 |
artikel |
9 |
Cover Story
|
|
|
|
15 |
3 |
p. xv |
artikel |
10 |
Diabetes-associated sleep fragmentation impairs liver and heart function via SIRT1-dependent epigenetic modulation of NADPH oxidase 4
|
Guo, Yuanfang |
|
|
15 |
3 |
p. 1480-1496 |
artikel |
11 |
Dihydromyricetin mitigates abdominal aortic aneurysm via transcriptional and post-transcriptional regulation of heme oxygenase-1 in vascular smooth muscle cells
|
Ye, Weile |
|
|
15 |
3 |
p. 1514-1534 |
artikel |
12 |
Discovery of a novel polymyxin adjuvant against multidrug-resistant gram-negative bacteria through oxidative stress modulation
|
Lu, Taotao |
|
|
15 |
3 |
p. 1680-1695 |
artikel |
13 |
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
|
Jin, Yuheng |
|
|
15 |
3 |
p. 1659-1679 |
artikel |
14 |
Disrupting calcium homeostasis and glycometabolism in engineered lipid-based pharmaceuticals propel cancer immunogenic death
|
Peng, Qiuxia |
|
|
15 |
3 |
p. 1255-1267 |
artikel |
15 |
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors
|
Zhang, Xiong |
|
|
15 |
3 |
p. 1415-1429 |
artikel |
16 |
eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through m6A modification
|
Ouyang, Qianying |
|
|
15 |
3 |
p. 1571-1588 |
artikel |
17 |
Engineered bacteria assist CAR-cell immunotherapy
|
Shao, Tianyu |
|
|
15 |
3 |
p. 1703-1705 |
artikel |
18 |
Erratum to “Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism” [Acta Pharm Sin B 14 (2024) 4883–4898]
|
Wang, Pengcheng |
|
|
15 |
3 |
p. 1717-1718 |
artikel |
19 |
Establishment of interpretable cytotoxicity prediction models using machine learning analysis of transcriptome features
|
Wu, You |
|
|
15 |
3 |
p. 1344-1358 |
artikel |
20 |
Evaluation of the efficacy and mechanisms of azvudine in elderly patients with malignant tumors complicated by COVID-19
|
Sun, Ranran |
|
|
15 |
3 |
p. 1712-1714 |
artikel |
21 |
Ginsenoside CK targets PHD2 to prevent platelet adhesion and enhance blood circulation by modifying the three-dimensional arrangement of collagen
|
Cheng, Chuanjing |
|
|
15 |
3 |
p. 1497-1513 |
artikel |
22 |
Intravenous delivery of STING agonists using acid-sensitive polycationic polymer-modified lipid nanoparticles for enhanced tumor immunotherapy
|
He, Ying |
|
|
15 |
3 |
p. 1211-1229 |
artikel |
23 |
Liquid–liquid phase separation-assembled coacervate vesicles for biopharmaceutical delivery
|
Ji, Zao |
|
|
15 |
3 |
p. 1709-1711 |
artikel |
24 |
Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis
|
Wang, Kaifeng |
|
|
15 |
3 |
p. 1383-1396 |
artikel |
25 |
Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence
|
Yang, Jiaqing |
|
|
15 |
3 |
p. 1696-1699 |
artikel |
26 |
Monocytes in the brain–heart crosstalk control sleep under myocardial infarction
|
Mao, Meng |
|
|
15 |
3 |
p. 1700-1702 |
artikel |
27 |
Nitazoxanide protects against heart failure with preserved ejection and metabolic syndrome induced by high-fat diet (HFD) plus L-NAME “two-hit” in mice
|
Chen, Jiahui |
|
|
15 |
3 |
p. 1397-1414 |
artikel |
28 |
Novel carbazole attenuates vascular remodeling through STAT3/CIAPIN1 signaling in vascular smooth muscle cells
|
Han, Joo-Hui |
|
|
15 |
3 |
p. 1463-1479 |
artikel |
29 |
Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis
|
Hong, Wenxiang |
|
|
15 |
3 |
p. 1626-1642 |
artikel |
30 |
Parabacteroides distasonis promotes liver regeneration by increasing β-hydroxybutyric acid (BHB) production and BHB-driven STAT3 signals
|
Guo, Manlan |
|
|
15 |
3 |
p. 1430-1446 |
artikel |
31 |
Parkin inhibits iron overload-induced cardiomyocyte ferroptosis by ubiquitinating ACSL4 and modulating PUFA-phospholipids metabolism
|
Xiao, Dandan |
|
|
15 |
3 |
p. 1589-1607 |
artikel |
32 |
Remodeling tumor immunosuppressive microenvironment through dual activation of immunogenic panoptosis and ferroptosis by H2S-amplified nanoformulation to enhance cancer immunotherapy
|
Luo, Yingli |
|
|
15 |
3 |
p. 1242-1254 |
artikel |
33 |
Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon
|
Kufa, Martin |
|
|
15 |
3 |
p. 1311-1332 |
artikel |
34 |
Silencing excessive stress response of neurons — a new approach to treat neurodegeneration diseases
|
Li, Chunyang |
|
|
15 |
3 |
p. 1706-1708 |
artikel |
35 |
STK39 inhibits antiviral immune response by inhibiting DCAF1-mediated PP2A degradation
|
Zhang, Chengfei |
|
|
15 |
3 |
p. 1535-1551 |
artikel |
36 |
Table of Contents
|
|
|
|
15 |
3 |
p. iii-xv |
artikel |
37 |
Targeting farnesoid X receptor as aging intervention therapy
|
Zhang, Lijun |
|
|
15 |
3 |
p. 1359-1382 |
artikel |
38 |
The ubiquitin–proteasome system: A potential target for the MASLD
|
Liu, Yue |
|
|
15 |
3 |
p. 1268-1280 |
artikel |
39 |
Unlocking the potential of the gut microbiome in liver regeneration: Benefits and mechanistic insights
|
Wei, Wenchao |
|
|
15 |
3 |
p. 1715-1716 |
artikel |
40 |
USP25 ameliorates vascular remodeling by deubiquitinating FOXO3 and promoting autophagic degradation of FOXO3
|
Chen, Yanghao |
|
|
15 |
3 |
p. 1643-1658 |
artikel |